P/E ratio
搜索文档
IVZ or CG: Which Is the Better Value Stock Right Now?
ZACKS· 2026-02-06 01:40
核心观点 - 文章旨在比较景顺与凯雷集团两只金融-投资管理股票,以确定当前更具价值的投资选择[1] - 通过结合Zacks评级与价值风格评分进行分析,景顺在盈利前景和估值指标上均优于凯雷集团,被认为是当前更佳的价值选择[2][3][6] 公司比较:Zacks评级与盈利前景 - 景顺目前Zacks评级为1(强力买入),凯雷集团为3(持有)[3] - Zacks评级青睐近期盈利预测获上调的股票,表明景顺的盈利前景正在改善[3] 公司比较:估值指标分析 - 景顺的远期市盈率为10.07,低于凯雷集团的12.56[5] - 景顺的市盈增长比率为0.48,显著低于凯雷集团的1.04,显示其估值在考虑预期盈利增长后更具吸引力[5] - 景顺的市净率为0.92,远低于凯雷集团的3.09,表明其市场价值相对于账面价值更低估[6] 公司比较:综合价值评分 - 基于市盈率、市销率、盈利率、每股现金流等多种关键基本面指标,景顺获得价值风格评分A级,而凯雷集团获得C级[4][6] - 凭借稳健的盈利前景和更优的估值指标,景顺被认为是当前更优越的价值选择[6]
TELFY or CHT: Which Is the Better Value Stock Right Now?
ZACKS· 2026-01-31 01:40
Investors looking for stocks in the Diversified Communication Services sector might want to consider either Telefonica (TELFY) or Chunghwa (CHT) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes compa ...
COO vs. WST: Which Stock Should Value Investors Buy Now?
ZACKS· 2026-01-29 01:41
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both The Cooper Companies (COO) and West Pharmaceutical Services (WST) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a prove ...
DHLGY vs. EXPD: Which Stock Should Value Investors Buy Now?
ZACKS· 2026-01-27 01:40
Investors interested in stocks from the Transportation - Services sector have probably already heard of DHL Group Sponsored ADR (DHLGY) and Expeditors International (EXPD) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on ...
GBOOY vs. SOFI: Which Stock Is the Better Value Option?
ZACKS· 2026-01-22 01:40
Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Grupo Financiero Banorte SAB de CV (GBOOY) and SoFi Technologies, Inc. (SOFI) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank emphasize ...
BUR vs. AXP: Which Stock Should Value Investors Buy Now?
ZACKS· 2026-01-15 01:41
文章核心观点 - 文章旨在比较Burford Capital Limited (BUR)与美国运通(AXP)两只金融-综合服务类股票的价值投资机会 基于Zacks评级和价值评分体系 BUR在盈利前景和估值指标上均优于AXP 被认为是当前更优的价值选择 [1][7] 估值指标比较 - BUR的远期市盈率为6.18 远低于AXP的20.41 [5] - BUR的市盈增长比(PEG)为0.16 显著低于AXP的1.50 显示其估值在考虑盈利增长后更具吸引力 [5] - BUR的市净率为0.66 表明其市场价值低于账面价值 而AXP的市净率高达7.61 [6] 投资评级与价值评分 - BUR的Zacks评级为2(买入) 反映其盈利预测近期获得积极上调 盈利前景改善 AXP的评级为3(持有) [3] - 在价值评分体系中 BUR获得A级 而AXP获得C级 表明BUR在多项关键估值指标上被认定为低估 [6] 价值投资方法论 - 价值投资者通常采用市盈率、市销率、收益收益率、每股现金流等多种传统指标来判断公司公允价值与股票是否被低估 [4] - 将强劲的Zacks评级与出色的价值评分相结合 被证明能产生最佳回报 [2]
TLK or CHT: Which Is the Better Value Stock Right Now?
ZACKS· 2026-01-15 01:41
文章核心观点 - 文章通过对比PT Telekomunikasi (TLK)和Chunghwa (CHT)的估值指标与Zacks评级,认为TLK目前提供了更优的价值投资机会 [1][7] 估值指标对比 - TLK的远期市盈率为14.16,显著低于CHT的24.93 [5] - TLK的市盈增长比(PEG)为2.98,低于CHT的5.29 [5] - TLK的市净率为2.32,略低于CHT的2.49 [6] - 基于一系列估值指标,TLK的价值风格得分为B,而CHT的价值风格得分为D [6] 分析师评级与盈利前景 - TLK的Zacks评级为2(买入),而CHT的评级为3(持有)[3] - TLK的盈利预测修正活动更为积极,表明其分析师前景正在改善 [3][7] 投资方法论背景 - 文章采用的方法论是结合Zacks评级和价值风格评分来寻找价值投资机会 [2] - 价值风格评分综合考虑了市盈率、市销率、盈利率、每股现金流等多种基本面指标 [4]
CLPBY vs. PEN: Which Stock Is the Better Value Option?
ZACKS· 2026-01-13 01:42
文章核心观点 - 文章旨在比较两家医疗器械公司Coloplast A/S (CLPBY) 和 Penumbra (PEN) 的投资价值 并基于特定的价值评估模型得出结论 认为CLPBY目前是更优的价值投资选择 [1][6] 公司比较与投资价值分析 - Coloplast A/S (CLPBY) 的Zacks评级为2 (买入) 而Penumbra (PEN) 的评级为3 (持有) Zacks评级青睐近期盈利预测被上调的公司 表明CLPBY的盈利前景正在改善 [3] - CLPBY的远期市盈率为21.75倍 显著低于PEN的63.30倍 [5] - CLPBY的市盈增长比率(PEG)为0.84 该指标结合了市盈率和预期盈利增长率 PEN的PEG比率为1.97 [5] - CLPBY的市净率(P/B)为8.32倍 低于PEN的9.29倍 [6] - 基于多项估值指标 CLPBY的价值评级为B级 而PEN的价值评级为D级 [6] 估值方法论 - 价值投资模型结合了Zacks评级和风格评分系统中的价值类别评分 Zacks评级主要关注盈利预测的上调趋势 [2] - 价值类别评分通过一系列关键指标来识别被低估的公司 包括市盈率(P/E)、市销率(P/S)、收益率、每股现金流等 [4]
SYIEY vs. GVDNY: Which Stock Is the Better Value Option?
ZACKS· 2026-01-09 01:40
文章核心观点 - 文章旨在比较两家特种化学品公司Symrise AG (SYIEY)和Givaudan SA (GVDNY) 对价值投资者的吸引力 并基于Zacks评级和价值评分体系得出结论 [1] - 分析认为 基于更优的Zacks排名和多项估值指标 Symrise AG (SYIEY) 是目前更具吸引力的价值投资选择 [7] 公司比较与投资评级 - Symrise AG (SYIEY) 目前的Zacks排名为第2级(买入) 而Givaudan SA (GVDNY) 的Zacks排名为第4级(卖出) Zacks排名强调盈利预测修正 SYIEY的盈利前景改善程度可能更大 [3] - 价值投资者通过分析多种传统指标来寻找他们认为在当前股价水平被低估的公司 [4] - 价值评分系统通过考察市盈率(P/E)、市销率(P/S)、收益率、每股现金流等多种关键基本面指标来识别被低估的公司 [4] 关键估值指标对比 - SYIEY的远期市盈率为15.84 而GVDNY的远期市盈率为23.73 [5] - SYIEY的市盈增长比率(PEG)为1.06 该指标同时考虑了公司的预期每股收益(EPS)增长率 而GVDNY的PEG比率为4.09 [5] - SYIEY的市净率(P/B)为2.63 该比率用于比较股票市值与其账面价值(总资产减总负债) 相比之下 GVDNY的市净率为7.24 [6] - 基于上述及其他多项估值指标 SYIEY获得了价值评分B级 而GVDNY获得了价值评分D级 [6]
RIO vs. WPM: Which Stock Is the Better Value Option?
ZACKS· 2026-01-08 01:41
文章核心观点 - 力拓公司目前相比惠顿贵金属公司为投资者提供了更好的价值投资机会 基于其强劲的盈利前景和更具吸引力的估值指标 [1][6] 公司比较与投资框架 - 寻找优质价值股的方法是结合强劲的Zacks评级和优秀的价值风格评分 [2] - 力拓目前的Zacks评级为1级 代表强力买入 而惠顿贵金属的评级为3级 代表持有 [3] - Zacks评级青睐近期盈利预测获得上修的公司 表明力拓的盈利前景正在改善 [3] - 价值投资者通过分析一系列传统指标来判断公司是否在当前股价水平被低估 [4] 估值指标分析 - 力拓的远期市盈率为12.04倍 远低于惠顿贵金属的37.78倍 [5] - 力拓的市盈增长比率为0.96 低于惠顿贵金属的1.32 [5] - 力拓的市净率为1.72 显著低于惠顿贵金属的7.04 [6] - 基于这些估值指标 力拓获得了B的价值评分 而惠顿贵金属的价值评分为F [6]